<DOC>
	<DOC>NCT02752503</DOC>
	<brief_summary>The objective is to study the effectiveness of Nalmefene in decreasing alcohol intake in subjects with alcohol use disorder and comorbid BPD.</brief_summary>
	<brief_title>Nalmefene in Alcohol Dependence and Borderline Personality Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Nalmefene</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Alcohol use disorder according to DSM 5 Borderline personality disorder according to DSM 5 CGIBPD &gt; 3 Female have to use contraception Other axis I disorders Severe organic disorder Pregnancy or breastfeeding Allergy to Nalmefene Subjects with Opioids use disorder or in treatment with opioid agonists</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>